- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03203291
Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients
June 2, 2020 updated by: Sunil Agrawal, Columbia University
The Integration of Motor Learning Principles to Reduce Load Asymmetry Using a Novel Robotic Device in Individuals Chronically Post-Stroke
OBJECTIVES: The purpose of this study is to evaluate the overall feasibility in terms of safety, treatment tolerance and adherence as well as preliminarily address how effective this treatment model using the TPAD and overground training would be to reduce load asymmetry on the treadmill and promote increased stance symmetry on the paretic limb during overground gait.PARTICIPANTS: A total of 12 individuals in the chronic (>6 months) stages post stroke will be recruited from a voluntary stroke research database for participation.
DESIGN: A non-randomized pilot study of feasibility will be used to establish the feasibility and preliminary efficacy of using the TPAD in combination with overground training to reduce load force asymmetry in this population.
METHODS: Participants will undergo a series of three assessments within a one-week time frame prior to initiating intervention.
Intervention using the TPAD and overground training will occur during week 2 over 5 consecutive visits (Mon-Fri).
Participants will also complete short walks before and after the intervention with an instrumented system that records individual walking characteristics.
Participants will return one-week after completing the intervention for a final test of walking and balance.
Each study visit will be approximately 1-1.5 hours in duration, and total participation should be completed within three weeks.
EXPECTED OUTCOMES: We anticipate this training paradigm will prove feasible and effective in reducing both load and stance asymmetry in a population of individuals with chronic stroke.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
There are a number of common impairments resulting from stroke that contribute to motor deficits which affect gait, or walking ability.
These manifest as decreased walking speed, and further, as stroke affects only one side of the body, there are resulting asymmetries in time, spatial and force parameters during walking.
Robotic-based therapies have been used to increase walking speed and reduce asymmetry in a population of individuals after stroke, however these therapies have demonstrated results similar to that of non-robotic, or conventional training.
This is possibly due to the control strategies used in robotic training, which strategies limit participant involvement and reduce learning effect.
The Tethered Pelvic Assist Device (TPAD) is a robotic device that uses motorized tethers attached to a belt at the user's pelvis to guide the pelvis along a pre-set movement trajectory.
These tethers can be configured in an infinite array of possibilities, and most recently have been used to facilitate a body weight shift onto the paretic limb in a population of individuals after stroke.
Other robotic devices constrain the limb through the entire movement trajectory and constrict the participants ability to participate in motor planning and movement execution.
The TPAD promotes weight shifting, but allows an individual to freely move the limb and to navigate leg movement and foot placement independently, without constraints.
Further, if coupled with overground training to promote transfer of improvements to walking over ground, this device maybe useful at improving symmetry in individuals after stroke.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic (>6 months) post stroke
- Single stroke event
- Montreal Cognitive Assessment (MoCA) score of >22
- Independently ambulating in the home
- Use of a unilateral assistive device (e.g. cane)
- Marked asymmetry in stance phase (defined by a symmetry ratio < 0.90)
Exclusion Criteria:
- History of multiple strokes
- History of other neurological disease
- Uncontrolled medical issues
- Muscle contractures of the lower limb limiting range of motion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tethered Pelvic Assist Device (TPAD) Treatment
All participants will receive 5 consecutive days of training with the TPAD (tethered pelvic assist device) with testing completed before training, on completion of training and at a 1-week follow up.
|
Each day of intervention will include a 1-hour treadmill based intervention to promote increased loading onto the affected limb.
Visual feedback will be provided and faded over the course of the 5-day training.
Immediately on completion of the treadmill intervention, participants will receive an additional 5-10 minutes of overground intervention reinforcing weight shifting onto the affected limb.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Force Symmetry Ratio During Gait
Time Frame: Baseline through day 5
|
0-1 symmetry ratio comparing the impulse force of the affected limb versus the unaffected limb during gait.
If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1.
The greater the disparity between limbs, the closer the ratio is to 0.
|
Baseline through day 5
|
|
Stance Time Symmetry Ratio
Time Frame: Baseline through week 3
|
0-1 symmetry ratio of the percentage of time spent in the stance phase of a gait cycle. If the unaffected limb performs equivalent to the affected limb, the ratio will have a value of 1. The greater the disparity the closer the ratio is to 0. Stance time symmetry = Time in stance phase of gait cycle of Affected/Unaffected limb. |
Baseline through week 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symmetry Ratio of Stride Length
Time Frame: Baseline through week 3
|
0-1 symmetry ratio comparing the stride length of the affected limb versus the unaffected limb during gait.
If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1.
The greater the disparity between limbs, the closer the ratio is to 0.
|
Baseline through week 3
|
|
Gait Velocity
Time Frame: Baseline through week 3
|
Walking velocity (speed) measured in meters walked per second (measured by Inertial Measurement Unit sensors worn in real time during walking).
|
Baseline through week 3
|
|
Symmetry of Percentage of Time in Swing Phase of Gait
Time Frame: Baseline through week 3
|
0-1 symmetry ratio compares the amount of time the unaffected leg is in swing phase of the gait cycle compared to the affected leg.
The swing phase means the period of time during the gait cycle when one foot is not in contact with the ground.
If the unaffected limb performs equivalent to the affected limb, the ratio has a value of 1.
The greater the disparity between limbs, the closer the ratio is to 0.
|
Baseline through week 3
|
|
Time Spent in Double Support Phase of Gait
Time Frame: Baseline through week 3
|
The percentage of time in one gait cycle spent in double support phase of gait (2 feet in contact with the ground).
|
Baseline through week 3
|
|
Berg Balance Scale
Time Frame: Baseline through week 3
|
Berg Balance Scale measures balance ability of adults.
The scale has 14 items, each is rated on a 5-point scale ranging from 0-4.
A score of 0 indicates the lowest level of function and 4 indicating the highest level of function.
Total scores range from 0-56, with higher scores indicating better balance.
|
Baseline through week 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sunil Agrawal, PhD, Columbia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2017
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
June 24, 2017
First Submitted That Met QC Criteria
June 28, 2017
First Posted (Actual)
June 29, 2017
Study Record Updates
Last Update Posted (Actual)
June 9, 2020
Last Update Submitted That Met QC Criteria
June 2, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAR2407
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on TPAD (Tethered Pelvic Assist Device)
-
Kessler FoundationRecruitingSCI - Spinal Cord InjuryUnited States
-
Kessler FoundationRecruiting
-
Altec Inc.Columbia UniversityCompletedCerebral Palsy | Gait Disorders, NeurologicUnited States
-
Stanford UniversityTauTona GroupActive, not recruiting
-
Stanford UniversityTauTona GroupCompletedLaparoscopic SurgeryUnited States
-
University of North Carolina, Chapel HillWithdrawnCOPD | Chronic BronchitisUnited States
-
Columbia UniversityMayo Clinic; University of PennsylvaniaCompletedBarrett Esophagus | Esophageal AdenocarcinomaUnited States
-
University of North Carolina, Chapel HillParion SciencesCompletedLung DiseasesUnited States
-
Mayo ClinicActive, not recruiting
-
Assiut UniversityNot yet recruiting